Flow cytometric DNA ploidy analysis of peripheral blood from patients with Sézary syndrome: Detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 774-782

  Wang, Sa ^a   Li, Ning ^a   Heald, Peter ^a   Fisk, John M ^a   Fadare, Oluwole ^a   Howe, John G ^a   McNiff, Jennifer M ^a   Smith, Brian R ^a,b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cutaneous T cell lymphoma; DNA ploidy; Flow cytometry; Immunophenotype; Large cell transformation; Minimal residual disease; S zary syndrome

Indexed keywords

ADULT; AGED; ANEUPLOIDY; BIOPSY; BLOOD ANALYSIS; BLOOD SAMPLING; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PERIPHERAL CIRCULATION; PLOIDY; PRIORITY JOURNAL; REVIEW; SCREENING; SEZARY SYNDROME; T CELL LYMPHOMA;

EID: 7244257596     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/8B849FC6PHAP8FDD     Document Type: Review

References (45)

1. Lutzner M, Edelson R, Schein P, et al. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides and related disorders. Ann Intern Med. 1975;83:534-552.
2. Sausville EA, Eddy JL, Makuch RW, et al. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Ann Intern Med. 1988;109:372-382.
3. Zackheim HS, Amin S, Kashani-Sabet M, et al. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol. 1999;40:418-425.
4. Buechner SA, Winkelmann RK. Sézary syndrome: a clinicopathologic study of 39 cases. Arch Dermatol. 1983;119:979-986.
5. Trotter MJ, Whittaker SJ, Orchard GE, et al. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol. 1997;24:286-291.
6. Willemze R, Van Vloten WA, Hermans J, et al. Diagnostic criteria in Sézary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol. 1983;81:392-397.
7. Harmon CB, Witzig TE, Katzmann JA, et al. Detection of circulating T cells with CD4+CD7-immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol. 1996;35:404-410.
8. Bogen SA, Pelley D, Charif M, et al. Immunophenotypic identification of Sézary cells in peripheral blood. Am J Clin Pathol. 1996;106:739-748.
9. Olah E, Balogh E, Kajtar P, et al. Diagnostic and prognostic significance of chromosome abnormalities in childhood acute lymphoblastic leukemia. Ann N Y Acad Sci. 1997;824:8-27.
10. Nikolaeva TG, Dobrynin IaV, Letiagin VP, et al. The experience in the use of DNA flow cytometry to predict the natural history of malignant neoplasms [in Russian]. Vestn Ross Akad Med Nauk. January 2002:45-54.
11. Magennis DP. Nuclear DNA in histological and cytological specimens: measurement and prognostic significance. Br J Biomed Sci. 1997;54:140-448.
12. Duque RE, Andreeff M, Braylan RC, et al. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry. 1993;14:492-496.
13. Braylan RC. Flow-cytometric DNA analysis in the diagnosis and prognosis of lymphoma. Am J Clin Pathol. 1993;99:374-380.
14. Horii A, Yoshida J, Hattori K, et al. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry. Head Neck. 1998;20:392-398.
15. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95-106.
16. Johnson GA, Dewald GW, Strand WR, et al. Chromosome studies in 17 patients with the Sézary syndrome. Cancer. 1985;55:2426-2433.
17. Vonderheid EC, Kantor GR, Pequignot EC, et al. Analysis of clinical, histologic and immunopathologic parameters in erythrodermic variants of cutaneous T-cell lymphoma with implication for staging. In: Lambert WC, Giannotti B, van Vloten WA, eds. Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin. New York, NY: Plenum Press; 1994:275-290.
18. Thangavelu M, Finn WG, Yelavarthi KK, et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood. 1997;89:3371-3377.
19. Dmitrovsky E, Matthews MJ, Bunn PA, et al. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987;5:208-215.
20. Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood. 1998;92:1150-1159.
21. Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T-cell lymphoma to large-cell lymphoma: a clinicopathologic and immunologic study. Am J Pathol. 1988;132:265-277.
22. Greer JP, Salhany KE, Cousar JB, et al. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large-cell process. Hematol Oncol. 1990;8:215-227.
23. Wolfe JT, Chooback L, Finn DT, et al. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. J Clin Oncol. 1995;13:1751-1757.
24. Wood GS, Hoppe RT, Warnke RA, et al. Evidence that mycosis fungoides (MF) and transformed MF arise from the same T-cell clone [abstract]. J Cutan Pathol. 1991;18:397.
25. Ralfkiaer E, Larsen JK, Christensen IJ, et al. DNA analysis by flow cytometry in cutaneous T cell lymphomas. Br J Dermatol. 1989;120:597-605.
26. Bunn PA Jr, Whang-Peng J, Carney DN, et al. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest. 1980;65:1440-1448.
27. So CC, Wong KF, Siu LL, et al. Large cell transformation of Sézary syndrome: a conventional and molecular cytogenetic study. Am J Clin Pathol. 2000;113:792-797.
28. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
29. Fraser-Andrews E, Seed P, Whittaker S, et al. Extracorporeal photopheresis in Sézary syndrome: no significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol. 1998;134:1001-1005.
30. Orfao A, Ciudad J, Gonzalez M, et al. Flow cytometry in the diagnosis of cancer. Scand J Clin Lab Invest. 1995;55:145-152.
31. Diss TC, Watts M, Pan LX, et al. The polymerase chain reaction in the demonstration of monoclonality in T cell lymphomas. J Clin Pathol 1995;48:1045-1050.
32. Lefranc MP, Forster A, Rabbitts TH. Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. Nature. 1986;319:420-422.
33. Lima M, Almeida J, dos Anjos Teixeira M, et al. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome. Haematologica. 2003;88:874-887.
34. Whang-Peng J, Bunn PA, Knutsen T, et al. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982;50:1539-1553.
35. Nowell PC, Finan JB, Vonderheid EC. Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes and skin. J Invest Dermatol. 1982;78:69-75.
36. Clausen OP, Olsen G, Tjonnfjord GE. Flow cytometry: use in cell biology and benefits in clinical medicine [in Norwegian]. Tidsskr Nor Laegeforen. 2000;120:489-495.
37. Pope B, Brown R, Gibson J, et al. The bone marrow plasma cell labeling index by flow cytometry. Cytometry. 1999;38:286-292.
38. Vergier B, de Muret A, Beylot-Barry M, et al, for the French Study Group of Cutaneous Lymphomas. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. Blood. 2000;95:2212-2218.
39. Stefanato CM, Tallini G, Crotty PL. Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T-cell lymphoma? Am J Dermatopathol. 1998;20:1-6.
40. Li G, Chooback L, Wolfe JT, et al. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol. 1998;110:767-770.
41. Li G, Salhany KE, Rook AH, et al. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol. 1997;24:403-408.
42. Vonderheid EC, Fang SM, Helfrich MK, et al. Biophysical characterization of normal T-lymphocytes and Sézary cells. J Invest Dermatol. 1981;76:28-37.
43. D'Alessandro E, De Pasquale A, Ligas C, et al. Cytogenetic findings in terminal large cell transformation in a case of Sézary syndrome. Cancer Genet Cytogenet. 1992;58:100-104.
44. Matutes E, Schulz T, Dyer M, et al. Immunoblastic transformation of a Sézary syndrome in a black Caribbean patient without evidence of HTLV-I. Leuk Lymphoma. 1995;18:521-527.
45. Karenko L, Sarna S, Kahkonen M, et al. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol. 2003;148:55-64.